Calcineurin inhibitors: friend and foe?

M. Iversen (Copenhagen, Denmark)

Source: School Course 2012 - Lung Transplantation

Number: 22

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Iversen (Copenhagen, Denmark). Calcineurin inhibitors: friend and foe?. School Course 2012 - Lung Transplantation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Infection: friend or foe to the development of asthma? Source: Eur Respir J 2001; 18: 744-747 Year: 2001
Inflammation: friend or foe of muscle remodelling in COPD? Source: Eur Respir J 2007; 30: 605-607 Year: 2007
Bacterial colonisation in COPD: friend or foe? Source: Annual Congress 2010 - PG11 Postgraduate Course: Infection: a player in the natural history of COPD Year: 2010
Inhaled corticosteroids in COPD: friend or foe? Source: Eur Respir J, 52 (6) 1801219; 10.1183/13993003.01219-2018 Year: 2018
Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe? Source: Eur Respir J 2016; 48: 1230-1233 Year: 2016
Mechanical ventilation: a friend and a foe Source: International Congress 2015 – ME3 Mechanical ventilation: a friend and a foe Year: 2015
Cellular senescence: friend or foe to respiratory viral infections? Source: Eur Respir J, 56 (6) 2002708; 10.1183/13993003.02708-2020 Year: 2020
Oxygen, the lung and the diver: friends and foes? Source: Eur Respir Rev 2016; 25: 496-505 Year: 2016
To tracheostomize or not to tracheostomize? Source: Eur Respir J 2005; 26: Suppl. 49, 393s Year: 2005
Mycobacterium chelonei: friend or foe? Source: Eur Respir J 2007; 30: 397 Year: 2007
Tyrosine kinase inhibitors beyond progression: never, intercalating or forever? Source: International Congress 2015 – Non-small cell lung cancer (NSCLC): sequence, timing, and modality of multi-line therapies Year: 2015
Interleukin-6 as a biomarker for asthma: hype or is there something else? Source: Eur Respir J 2016; 48: 979-981 Year: 2016
The "Coil Associated Opacity" in endoscopic emphysema treatment. Friend or foe? Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018
Adaptation to oxidative stress induced-lung injury: friend or foe of influenza infection? Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018
Tobacco smoke: old foe more important for asthma than commonly appreciated? Source: Eur Respir J 2004; 24 : 720-721 Year: 2004